Gritstone bio, Inc. (GRTS) financial statements (2022 and earlier)

Company profile

Business Address 5959 HORTON STREET, SUITE 300
EMERYVILLE, CA 94608
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments201,633171,058127,776153,110
Cash and cash equivalents93,287170,05657,40852,183
Short-term investments108,3461,00270,368100,927
Restricted cash and investments11,285   
Prepaid expense1,7691,4801,2521,826
Other current assets866268290449
Other undisclosed current assets5,0372,5841,9552,251
Total current assets:220,590175,390131,273157,636
Noncurrent Assets
Operating lease, right-of-use asset22,92021,34423,427
Property, plant and equipment21,62222,10526,91129,494
Long-term investments and receivables4,617   
Long-term investments4,617   
Restricted cash and investments6,005992992992
Other noncurrent assets   250
Other undisclosed noncurrent assets2,3521,7361,7861,186
Total noncurrent assets:57,51646,17753,11631,922
TOTAL ASSETS:278,106221,567184,389189,558
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities11,56616,58610,2609,768
Accounts payable4,2309,5784,6214,825
Accrued liabilities4116771,041992
Employee-related liabilities6,9256,3314,5983,951
Deferred revenue17,2013,4754,956
Debt  2,505 
Contract with customer, liability5,340
Other undisclosed current liabilities11,1896,9271,779 
Total current liabilities:39,95626,98819,50015,108
Noncurrent Liabilities
Long-term debt and lease obligation18,93619,22520,985 
Operating lease, liability18,93619,22520,985
Liabilities, other than long-term debt3,1288,6159,56014,838
Deferred revenue3,1288,2209,560
Contract with customer, liability13,473
Deferred rent credit   1,353
Other liabilities 395 12
Other undisclosed noncurrent liabilities   10,490
Total noncurrent liabilities:22,06427,84030,54525,328
Total liabilities:62,02054,82850,04540,436
Stockholders' equity
Stockholders' equity attributable to parent216,086166,739134,344149,122
Common stock20181716
Additional paid in capital617,523493,023355,291275,593
Accumulated other comprehensive income (loss)(73) 24(85)
Accumulated deficit(401,384)(326,302)(220,988)(126,402)
Total stockholders' equity:216,086166,739134,344149,122
TOTAL LIABILITIES AND EQUITY:278,106221,567184,389189,558

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
Revenues48,2144,0374,3651,187
Gross profit:48,2144,0374,3651,187
Operating expenses(123,423)(110,054)(102,305)(66,771)
Operating loss:(75,209)(106,017)(97,940)(65,584)
Net loss:(75,209)(106,017)(97,940)(65,584)
Other undisclosed net income attributable to parent1277033,507809
Net loss available to common stockholders, diluted:(75,082)(105,314)(94,433)(64,775)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
Net loss:(75,209)(106,017)(97,940)(65,584)
Comprehensive loss:(75,209)(106,017)(97,940)(65,584)
Other undisclosed comprehensive income, net of tax, attributable to parent546793,616798
Comprehensive loss, net of tax, attributable to parent:(75,155)(105,338)(94,324)(64,786)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: